Matrix Global Advisors
Teva Economic Impact Report

Teva Economic Impact Report

Jul 28, 2021 | Analysis

Teva Economic Impact Report This report, from Matrix Global Advisors (MGA), highlights Teva’s impact on economies in 15 of the 60 countries in which Teva operates. These 15 countries comprise 60 percent of Teva’s total global workforce and 75 percent of revenues in...
MGA Report Comes in at Number One at The Center for Biosimilars

MGA Report Comes in at Number One at The Center for Biosimilars

Jun 18, 2021 | News

MGA Report Comes in at Number One at The Center for Biosimilars The Center for Biosimilars has announced that MGA’s recent report, “How Patent Thickets Constrain the US Biosimilars Market and Domestic Manufacturing,” was the top-read article on its...
MGA Report Featured by The Center for Biosimilars

MGA Report Featured by The Center for Biosimilars

Jun 10, 2021 | News

MGA Report Featured by The Center for Biosimilars On Thursday, The Center for Biosimilars, a sister site of The American Journal of Managed Care, published an article discussing the differences between the patent systems in the United States and Europe when it comes...
Shared Savings Models Could Yield Part B Savings

Shared Savings Models Could Yield Part B Savings

Jun 10, 2020 | News

Shared Savings Models Could Yield Part B Savings Skylar Jeremias | The Center for Biosimilars “The establishment of a shared savings model has the potential to increase health care savings, biologic competition, and biosimilar utilization if implemented in...